Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy

T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy

US Patent 12076344 · Granted Sep 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Anti-CD30 antibodies2025
Anti-CD30 antibodies2025
ALS treatment using induced regulatory T (iTREG) cells2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
Recombinant PD-L1 peptides and methods of use2024
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
In vitro and in vivo enrichment strategy targeting lymphocytes derived from vect2023